1. Home
  2. HAO vs ENSC Comparison

HAO vs ENSC Comparison

Compare HAO & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAO
  • ENSC
  • Stock Information
  • Founded
  • HAO 2018
  • ENSC 2003
  • Country
  • HAO China
  • ENSC United States
  • Employees
  • HAO N/A
  • ENSC N/A
  • Industry
  • HAO
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • HAO
  • ENSC Health Care
  • Exchange
  • HAO NYSE
  • ENSC Nasdaq
  • Market Cap
  • HAO 3.3M
  • ENSC 2.9M
  • IPO Year
  • HAO 2024
  • ENSC N/A
  • Fundamental
  • Price
  • HAO $1.41
  • ENSC $3.29
  • Analyst Decision
  • HAO
  • ENSC
  • Analyst Count
  • HAO 0
  • ENSC 0
  • Target Price
  • HAO N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • HAO 68.3K
  • ENSC 4.9M
  • Earning Date
  • HAO 05-31-2025
  • ENSC 05-12-2025
  • Dividend Yield
  • HAO N/A
  • ENSC N/A
  • EPS Growth
  • HAO 20.20
  • ENSC N/A
  • EPS
  • HAO 0.19
  • ENSC N/A
  • Revenue
  • HAO $48,970,924.00
  • ENSC $5,210,031.00
  • Revenue This Year
  • HAO N/A
  • ENSC N/A
  • Revenue Next Year
  • HAO N/A
  • ENSC N/A
  • P/E Ratio
  • HAO $6.91
  • ENSC N/A
  • Revenue Growth
  • HAO 71.88
  • ENSC 133.58
  • 52 Week Low
  • HAO $0.09
  • ENSC $1.62
  • 52 Week High
  • HAO $10.60
  • ENSC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • HAO 53.02
  • ENSC 55.92
  • Support Level
  • HAO $1.08
  • ENSC $3.02
  • Resistance Level
  • HAO $1.40
  • ENSC $4.85
  • Average True Range (ATR)
  • HAO 0.17
  • ENSC 0.40
  • MACD
  • HAO 0.03
  • ENSC 0.27
  • Stochastic Oscillator
  • HAO 87.97
  • ENSC 51.70

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: